CIK: 1652410 - Address: C/O Xeris Biopharma Holdings, Inc., 1375 West Fulton Street, Suite 1300, Chicago, IL 60607
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/15/23 17:00
6/15/23
ITRMIterum Therapeutics PlcL2HealthDrugPharmaceutical PreparationsHecht BethL2DM.d00.0001653119D
6/24/22 18:00
6/23/22
ITRMIterum Therapeutics PlcL2HealthDrugPharmaceutical PreparationsHecht BethL2DM.d00.0003746045D
3/22/22 19:00
3/18/22
ITRMIterum Therapeutics PlcL2HealthDrugPharmaceutical PreparationsHecht BethL2DM.d00.0008999%8D
3/16/20 16:07
3/13/20
XERSXeris Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsHecht BethILOSee RemaP81.9704857D
2/18/20 17:02
2/14/20
XERSXeris Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsHecht BethILOSee RemaP174.1504988D
2/22/19 16:36
2/19/19
XERSXeris Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsHecht BethILOSee RemaP2510.0003New3D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact